🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to evaluate the safety and tolerability of VRB-103...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-07-06
Trial ID
NCT07628127
The purpose of this study is to identify the weekly oral dose of VRB-101 (o...
Status
Active Not Recruiting
Location
Clinical Study Site 202
Start Date
2026-06-12
Trial ID
NCT07553299
The aim of this study is to evaluate the efficacy of VRB-101 for body weigh...
Status
Completed
Location
Clinical Study Site 103
Start Date
2025-11-25
Trial ID
NCT07281937
XW004 is an acylated human glucagon-like peptide 1 (GLP-1) analogue and is ...
Status
Completed
Location
Q-Pharm Pty Ltd (AKA Nucleus Network Brisbane)
Start Date
2022-04-12
Trial ID
NCT05184322
The aim of the study is to evaluate the safety, tolerability, pharmacokinet...
Status
Recruiting
Location
China-Japan Friendship Hospital
Start Date
2025-11-18
Trial ID
NCT07243171
Treatments Being Tested